PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
American Oncology Network Inc. (AONC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

SectorHealthcare
IndustryMedical Care Facilities

Highlights

Market Cap$44.31M
EPS (TTM)-$2.94
Total Revenue (TTM)$1.12B
Gross Profit (TTM)$47.40M
EBITDA (TTM)-$29.92M
Year Range$1.01 - $9.24
Short %0.39%
Short Ratio0.63

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in American Oncology Network Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%MayJuneJulyAugustSeptemberOctober
-37.95%
11.17%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Returns By Period

American Oncology Network Inc. had a return of -42.37% year-to-date (YTD) and -45.92% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-42.37%21.18%
1 month4.62%5.18%
6 months-37.96%11.17%
1 year-45.92%32.06%
5 years (annualized)N/A14.28%
10 years (annualized)N/A11.94%

Monthly Returns

The table below presents the monthly returns of AONC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-10.34%12.85%-8.04%-30.42%-12.57%-68.56%166.67%29.93%7.20%-42.37%
20230.75%0.79%1.47%-1.26%0.49%0.49%2.91%-0.94%-11.60%-34.68%18.19%-17.83%-41.26%
2022-0.62%0.26%0.46%0.20%0.05%-0.05%0.41%-0.10%0.10%1.22%-0.00%1.06%3.03%
20210.94%0.52%-0.41%-0.93%0.94%0.21%0.31%-0.00%1.56%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AONC is 25, indicating that it is in the bottom 25% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of AONC is 2525
AONC (American Oncology Network Inc.)
The Sharpe Ratio Rank of AONC is 2323Sharpe Ratio Rank
The Sortino Ratio Rank of AONC is 3333Sortino Ratio Rank
The Omega Ratio Rank of AONC is 3232Omega Ratio Rank
The Calmar Ratio Rank of AONC is 1515Calmar Ratio Rank
The Martin Ratio Rank of AONC is 2222Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for American Oncology Network Inc. (AONC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AONC
Sharpe ratio
The chart of Sharpe ratio for AONC, currently valued at -0.37, compared to the broader market-4.00-2.000.002.00-0.37
Sortino ratio
The chart of Sortino ratio for AONC, currently valued at 0.23, compared to the broader market-4.00-2.000.002.004.000.23
Omega ratio
The chart of Omega ratio for AONC, currently valued at 1.03, compared to the broader market0.501.001.502.001.03
Calmar ratio
The chart of Calmar ratio for AONC, currently valued at -0.51, compared to the broader market0.002.004.006.00-0.51
Martin ratio
The chart of Martin ratio for AONC, currently valued at -0.94, compared to the broader market-10.000.0010.0020.00-0.95
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.002.61
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.50, compared to the broader market-4.00-2.000.002.004.003.50
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.501.001.502.001.47
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.30, compared to the broader market0.002.004.006.002.30
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 15.90, compared to the broader market-10.000.0010.0020.0015.90

Sharpe Ratio

The current American Oncology Network Inc. Sharpe ratio is -0.37. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of American Oncology Network Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
-0.37
2.61
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


American Oncology Network Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-88.28%
-0.21%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the American Oncology Network Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the American Oncology Network Inc. was 96.38%, occurring on Jun 28, 2024. The portfolio has not yet recovered.

The current American Oncology Network Inc. drawdown is 88.28%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.38%Sep 19, 2023196Jun 28, 2024
-7.25%May 14, 20211May 14, 2021457Mar 9, 2023458
-2.76%Mar 10, 202315Mar 30, 202382Jul 28, 202397
-2.46%Sep 14, 20231Sep 14, 20231Sep 15, 20232
-1.41%Aug 3, 202315Aug 23, 202314Sep 13, 202329

Volatility

Volatility Chart

The current American Oncology Network Inc. volatility is 23.58%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%MayJuneJulyAugustSeptemberOctober
23.58%
2.84%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of American Oncology Network Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for American Oncology Network Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items